undamentalytics Newsletter

Wiesenthal Robert S: insider trades

Chief executive at Strata Critical Medical, Inc. No open-market purchases and 9 sales not made under a pre-set plan, reported from October 11, 2022 to November 15, 2024.

What happened after Wiesenthal Robert S’s sales?

None of these trades can be measured yet: either the window after the report has not finished or the share price was under $5 when it was reported.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Wiesenthal Robert S: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Strata Critical Medical, Inc. SRTA Chief Executive Officer09October 11, 2022November 15, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 15, 2024November 14, 2024 SRTA Sale $6,762,000 not yetnot yetnot yet
April 5, 2024April 3, 2024 SRTA Sale $83,371 not yetnot yetnot yet
March 15, 2024March 13, 2024 SRTA Sale $364,110 not yetnot yetnot yet
December 15, 2023December 13, 2023 SRTA Sale $299,025 not yetnot yetnot yet
October 6, 2023October 4, 2023 SRTA Sale $245,892 not yetnot yetnot yet
July 10, 2023July 6, 2023 SRTA Sale $794,724 not yetnot yetnot yet
April 11, 2023April 5, 2023 SRTA Sale $309,650 not yetnot yetnot yet
January 12, 2023January 9, 2023 SRTA Sale $37,733 not yetnot yetnot yet
October 11, 2022October 6, 2022 SRTA Sale $37,532 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Wiesenthal Robert S traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.